Mr Deepak Hariharan
Mr Deepak Hariharan is a Consultant General and Hepato-Pancreato-Biliary (HPB) Surgeon. His specialist interest includes treating all benign (non cancerous) and malignant conditions (cancers) affecting the liver, gallbladder, bile ducts and pancreas.
Advanced surgery for groin and abdominal hernias. Our fixed price packages offer a seamless service at The London Clinic.
20 consultants available
Mr Deepak Hariharan is a Consultant General and Hepato-Pancreato-Biliary (HPB) Surgeon at The Royal London Hospital since 2018, part of Barts Health NHS Trust, which is one of the largest NHS health care trusts in the country.
He graduated in 2001 from the Government Stanley Medical College and Hospital, Chennai, India. He was awarded MD (Research) degree in 2008 following the completion of thesis looking for biomarkers of pancreas cancer in urine using proteomic strategies from the Queen Mary University of London. He undertook Specialty General and HPB surgery training in the East Midlands at Queens Medical Centre, Nottingham, UK.
- Consultant HPB and General Surgery
The Royal London Hospital, Barts Health NHS Trust
- Colorectal liver metastases and other secondaries to liver
- Laparoscopic surgery
- Abdominal wall and groin hernias
- Primary liver cancers or HCC
- Biliary cancers
- Gallbladder cancer
- Solid and cystic tumours of pancreas
- Year qualified 2000
- Government Stanley Medical College and Hospital, Chennai, India 1995 - 2001
- Queen Mary University of London 2006 - 2008
- The Royal College of Surgeons Of England 2014
He completed the FRCS exit examination in 2014 and was awarded Certificate of Completion of Training in 2016. He undertook subspecialty HPB surgery fellowships at HPB units at Queen Elizabeth Hospital, Birmingham, UK, Royal London Hospital, London, UK and Verona, Italy a dedicated and renowned Pancreas Cancer Centre. His clinical research interest has been to facilitate early diagnosis and treatment in HPB cancers. He investigated potential diagnostic biomarkers in urine for pancreatic cancer. His seminal paper established urinary proteomics as a strategy for investigation of biomarkers for pancreas cancer.
In September 2019, Pancreas Cancer Research Fund, funded a £1.6M clinical study that would validate the accuracy and reliability of a urine test in detecting pancreatic cancer at an early stage.He has multiple peer-reviewed publications in HPB and General Surgery and is a tutor and mentor to undergraduate, post-graduate trainees and nurses.He is driven by quality improvement in surgery and is instrumental in setting up the one stop HPB cancer surgery assessment clinics, enhanced recovery in HPB cancer surgery, hot cholecystectomy pathway for suitable cases presenting as an emergency with symptomatic gallstones. He is motivated and focused on developing high performing surgical teams to improve quality of surgical care and enhance patient experience.